Bay­er kicks off a $150M add-on for its cam­pus in Berke­ley

Bay­er is blue­print­ing a new pro­duc­tion fa­cil­i­ty to add to its cam­pus in the Bay Area with a $150 mil­lion bud­get to com­plete the task.

On Thurs­day the com­pa­ny an­nounced that it will build a be­spoke 40,000-square-foot fa­cil­i­ty on its Berke­ley cam­pus, where they al­ready pro­duce he­mo­phil­ia A prod­ucts. The plan is to add on clin­i­cal pro­duc­tion op­er­a­tions at the new Cell Cul­ture Tech­nol­o­gy Cen­ter to sup­port their drug re­search work in on­col­o­gy, car­di­ol­o­gy and some oth­er spe­cial­ty health en­deav­ors.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.